Singapore’s Cordlife Group has made a US$7.50 per share bid for NYSE-listed Global Cord Blood Corporation (GCBC), China’s largest provider of cord blood storage and ancillary services. Under the proposal,…
Singapore’s Cordlife Group has made a US$7.50 per share bid for NYSE-listed Global Cord Blood Corporation (GCBC), China’s largest provider of cord blood storage and ancillary services. Under the proposal,…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference